{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:37:35Z","timestamp":1791653855463,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejmech.2023.115311","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:39:05Z","timestamp":1680233945000},"page":"115311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-4829","authenticated-orcid":false,"given":"Irina","family":"Stefanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-5000","authenticated-orcid":false,"given":"Carmen","family":"Cerchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Improta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Costanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-5554","authenticated-orcid":false,"given":"Sveva","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Morasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalaura","family":"Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sante","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2294-0656","authenticated-orcid":false,"given":"Francesco Saverio","family":"Di Leva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Storici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-3773","authenticated-orcid":false,"given":"Margherita","family":"Brindisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-6731","authenticated-orcid":false,"given":"Rolando","family":"Cannalire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6288-2681","authenticated-orcid":false,"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10224","key":"10.1016\/j.ejmech.2023.115311_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115311_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-NCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115311_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90278-4","article-title":"SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response","volume":"11","author":"Franzo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115311_bib4","series-title":"Human Coronaviruses","author":"Poutanen","year":"2005"},{"key":"10.1016\/j.ejmech.2023.115311_bib5","unstructured":"Brier, J.; lia dwi jayanti. https:\/\/coronavirus.jhu.edu\/map.html. https:\/\/coronavirus.jhu.edu\/map.html, (n.d.).."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115311_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2023.115311_bib7","series-title":"A Focus on Severe Acute Respiratory Syndrome (SARS) Coronavirus","first-page":"449","author":"Cannalire","year":"2022"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115311_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115311_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00044-021-02841-3","article-title":"Review on molnupiravir as a promising oral drug for the treatment of COVID-19","volume":"31","author":"Zarenezhad","year":"2022","journal-title":"Med. Chem. Res."},{"issue":"December","key":"10.1016\/j.ejmech.2023.115311_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 mproinhibitor clinical candidatefor the treatment of COVID-19","volume":"3","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115311_bib11","unstructured":"www.pardesbio.com\/pipeline\/#our-lead-program.."},{"key":"10.1016\/j.ejmech.2023.115311_bib12","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S - 217622, a noncovalent oral SARS-CoV - 2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115311_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection : emergence , transmission , and characteristics of human coronaviruses","volume":"24","author":"Adnan","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2023.115311_bib14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acs.jmedchem.0c01140","article-title":"Targeting SARS-CoV - 2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities","volume":"65","author":"Cannalire","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115311_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mbio.00869-22","article-title":"Genetic surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor Paxlovid","volume":"13","author":"Lee","year":"2022","journal-title":"mBio"},{"issue":"7811","key":"10.1016\/j.ejmech.2023.115311_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115311_bib17","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases : implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ejmech.2023.115311_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2023.115311_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-020-0356-z","article-title":"GC-376 , and calpain inhibitors II , XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","author":"Ma","year":"2020","journal-title":"Cell Res."},{"issue":"October","key":"10.1016\/j.ejmech.2023.115311_bib20","article-title":"Easy access to \u03b1 -ketoamides as SARS-CoV-2 and MERS M pro inhibitors via the PADAM oxidation route","volume":"244","author":"Pelliccia","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115311_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"issue":"March","key":"10.1016\/j.ejmech.2023.115311_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model","volume":"1378","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115311_bib23","first-page":"1","article-title":"Protease inhibitors for the treatment of hepatitis C virus infection 2013 improved SVR rates, the amount of severe side effects was high","volume":"5","author":"Leuw","year":"2017","journal-title":"GMS Infect. Dis."},{"issue":"23","key":"10.1016\/j.ejmech.2023.115311_bib24","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.bmcl.2013.09.070","article-title":"Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors","volume":"23","author":"Prior","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115311_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/ol047704o","article-title":"Unusual and unexpected reactivity of T-butyl dicarbonate (Boc2O) with alcohols in the presence of magnesium perchlorate. A new and general route to t-butyl ethers","volume":"7","author":"Bartoli","year":"2005","journal-title":"Org. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115311_bib26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.tet.2017.10.031","article-title":"Stereochemical basis for the anti-chlamydial activity of the phosphonate protease inhibitor JO146","volume":"74","author":"Agbowuro","year":"2018","journal-title":"Tetrahedron"},{"issue":"June","key":"10.1016\/j.ejmech.2023.115311_bib27","article-title":"A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals","volume":"240","author":"Ma","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2023.115311_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111779","article-title":"Structural and biochemical analysis of the dual inhibition of Mg-132 against sars-cov-2 main protease (Mpro\/3clpro) and human cathepsin-L","volume":"22","author":"Costanzi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6489","key":"10.1016\/j.ejmech.2023.115311_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"12 I","key":"10.1016\/j.ejmech.2023.115311_bib30","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular Graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115311_bib31","first-page":"861","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Struct. Biol."},{"issue":"32","key":"10.1016\/j.ejmech.2023.115311_bib32","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1074\/jbc.M115.651463","article-title":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus Nsp5 protease (3CLpro): implications for Nsp5 regulation and the development of antivirals","volume":"290","author":"Tomar","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2023.115311_bib33","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1016\/j.bmcl.2012.05.055","article-title":"Potent inhibition of norovirus 3CL protease by peptidyl \u03b1-Ketoamides and \u03b1-Ketoheterocycles","volume":"22","author":"Mandadapu","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115311_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-1139(97)00154-1","article-title":"A convenient synthesis of peptidyl perfluoroalkyl Ketones","volume":"88","author":"Cregge","year":"1998","journal-title":"J. Fluor. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115311_bib35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/acsptsci.0c00216","article-title":"Identification of inhibitors of SARS-CoV-2 3CL-pro enzymatic activity using a small molecule in vitro repurposing screen","volume":"4","author":"Kuzikov","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115311_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/abio.2000.4501","article-title":"High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants","volume":"281","author":"Kuzmi\u010d","year":"2000","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115311_bib37","doi-asserted-by":"crossref","DOI":"10.1140\/epjp\/i2015-15043-3","article-title":"Status of the crystallography beamlines at Elettra","volume":"130","author":"Lausi","year":"2015","journal-title":"Eur. Phys. J. Plus"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115311_bib38","doi-asserted-by":"crossref","DOI":"10.1107\/S090744499201028X","volume":"49","author":"Glusker","year":"1993","journal-title":"Biol. Crystallogr."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115311_bib39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115311_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115311_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:31Z","timestamp":1759330291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"alternative-id":["S0223523423002775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115311","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115311"}}